4.7 Review

Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases

期刊

BIOMEDICINE & PHARMACOTHERAPY
卷 133, 期 -, 页码 -

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2020.110985

关键词

Gallic acid; Pharmacodynamics; Inflammatory diseases; MAPK and NF-kappa B signaling pathways

资金

  1. National Key R&D Program of China [2017YFC1703904]
  2. China Postdoctoral Science Foundation [2020M683273]
  3. National Natural Science Foundation of China [81773974, 81903922, 81973569]
  4. State Administration of Traditional Chinese Medicine of the People's Republic of China [201507002]
  5. Major Science and Technology Project of Sichuan Science and Technology Department [19SYXHZ0095]
  6. Science & Technology Department of Sichuan Province [2018JY0467, 2020YFQ0032]
  7. Xinglin Scholar Research Premotion Project of Chengdu University of TCM [CXTD2018015, CXTD2018020]
  8. National College Students Innovation and Entrepreneurship Training Program [S201910633017]
  9. State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China [2020XSGG004]
  10. Project FirstClass Disciplines Development of Chengdu University of Traditional Chinese Medicine [CZYJC1903]

向作者/读者索取更多资源

Gallic acid is a natural secondary metabolite with potent anti-inflammatory properties, which may serve as a potential candidate for treating various inflammation-related diseases.
Gallic acid (GA), also known as 3,4,5-trihydroxybenzoic acid, is a natural secondary metabolite and widely isolated from various fruits, plants and nuts. In recent years, GA has received increasing attention for its powerful anti-inflammatory properties. The purpose of this review is to clearly illuminate the pharmacological activities and related molecular mechanisms of GA in inflammatory diseases. After consulting a large number of literatures, we made a comprehensive exposition on the chemical characteristics, plant origins, pharmacokinetics and toxicity of GA, especially its pharmacological activities and mechanisms of action. Although the plant source of GA is very rich, its lower extraction rate limits the application of GA in development. It is worth mentioning that GA can not only be separated from many plants, but also be produced in large quantities through biological and chemical synthesis. According to pharmacokinetic studies, the absorption and elimination of GA after oral administration are fast, while the structural optimization or dosage form adjustment of GA is beneficial to increase its bioavailability. Promisingly, toxicity studies have shown that GA scarcely has obvious toxicity or side effects in a variety of animal experiments and clinical trials. The results show that the anti-inflammatory mechanisms of GA mainly involved MAPK and NF-kappa B signaling pathways. It thus weakens the inflammatory response by reducing the release of inflammatory cytokines, chemokines, adhesion molecule and cell infiltration. Due to its excellent pharmacological activities, GA is expected to be a potential candidate for the treatment of various inflammation-related diseases. This paper will provide theoretical basis for the clinical application of GA and guide the future research and medicinal development of GA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据